Stephen Basso serves as the Chief Financial Officer (CFO) at Innoviva, Inc., a biopharmaceutical company focused on developing and commercializing innovative therapies. Basso brings extensive experience in financial management and strategic planning to his role, having spent over two decades in the healthcare and pharmaceutical industries. Prior to joining Innoviva, he held senior financial positions at several prominent companies, including The Medicines Company, where he served as CFO and played a pivotal role in guiding the company through significant growth and strategic transactions. At Innoviva, Basso is responsible for overseeing the company's financial operations, including financial planning and analysis, accounting, and investor relations. His strategic vision and leadership have been instrumental in strengthening Innoviva's financial position and supporting its growth initiatives. Under his guidance, the company has successfully navigated complex financial landscapes and maintained a strong balance sheet, which has been crucial for funding research and development efforts and pursuing new opportunities in the biopharmaceutical market. Basso's commitment to excellence and his ability to drive financial performance have made him a valuable asset to Innoviva and its stakeholders.